Transforming growth factors β1, β2 and β3 and their receptors are diffderentially expressed in human peritoneal fibroblasts in response to hypoxia

American Journal of Reproductive Immunology

Volumn 48, Issue 6, 2002, Pages 387-393

  Saed, Ghassan M ^a   Collins, Karen L ^a   Diamond, Michael P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Hypoxia; Multiplex RT PCR; Peritoneum; TGF s

Indexed keywords

BETA ACTIN; ISOPROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; HEALING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; PERITONEUM; PERITONEUM ADHESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ACTIVIN RECEPTORS, TYPE I; ADHESIONS; CELL HYPOXIA; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; PERITONEAL DISEASES; PERITONEUM; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; WOUND HEALING;

EID: 0036904524     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0897.2002.01090.x     Document Type: Article

References (28)

1. Diamond MP, Hershlag A: Adhesion formation/reformation. Prog Clin Biol Res 1990, 358: 23-33.
2. Holmdahl L, Risberg B, Beck DE, Burns JW, Chegini N, DiZerega GS, Ellis H: Adhesions: Pathogenesis and prevention-panel discussion and summary. Eur J Surg Suppl 1997; 577:56-62.
3. DiZerega GS: Biochemical events in peritoneal tissue repair. Eur J Surg Suppl 1997; 577:10-16.
4. Gomel V, Urman B, Gurgan T: Pathophysiology of adhesion formation and strategies for prevention. J Reprod Med 1996; 41:35-41.
5. Bittinger F, Schepp C, Brochhausen C, Lehr HA, Otto M, Kohler H, Skarke C, Walgenbach S, Kirkpatrick CJ: Remodeling of peritoneal-like structures by mesothelial cells: Its role in peritoneal healing. J Surg Res 1999; 82:28-33.
6. Holmdahl L, Risberg B, Beck DE, Burns JW, Chegini N, DiZerega GS, Ellis H: Adhesions: Pathogenesis and prevention-panel discussion and summary. Eur J Surg Suppl 1997; 577;56-62.
7. Chegini N: The role of growth factors in peritoneal healing: Transforming growth factor beta (tgf-beta). Eur J Surg Suppl 1997; 577:17-23.
8. Branton MH, Kopp JB: Tgf-beta and fibrosis. Microbes Infect 1999; 1:1349-1365.
9. Chambaz EM, Souchelnitskiy S, Pellerin S, Defaye G, Cochet C, Feige JJ: Transforming growth factors-betas: A multifunctional cytokine family. Implication in the regulation of adrenocortical cell endocrine functions. Horm Res 1996; 45:222-226.
10. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, Du Bois RM, Jeffery PK, McAnulty RJ: Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997; 150:981-991.
11. Frank S, Madlener M, Werner S: Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271:10188-10193.
12. Miyazono K, Heldin CH: Latent forms of tgr-beta: Molecular structure and mechanisms of activation. Ciba Found Symp 1991; 157:81-89.
13. Miyazono K, Heldin CH: The mechanism of action of transforming growth factor-beta. Gastroenterol Jpn 1993; 28:81-85 (discussion 86-87).
14. Lin HY, Moustakas A: Tgf-beta receptors: Structure and function. Cell Mol Biol (Noisy-le-Grand) 1994; 40:337-349.
15. Lawrence DA: Transforming growth factor-beta: A general review. Eur Cytokine Netw 1996; 7: 363-374.
16. Mita T, Yamashita H, Kaji Y, Obata H, Hanyu A, Suzuki M, Tobari I: Functional difference of tgf-beta isoforms regulating corneal wound healing after excimer laser keratectomy [letter]. Exp Eye Res 1999; 68:513-519.
17. O'Kane S, Ferguson MW: Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
18. Diamond MP: Reduction of adhesions after uterine myomectomy by seprafilm membrane (hal-f): A blinded, prospective, randomized, multicenter clinical study. Seprafilm adhesion study group. Fertil Steril 1996; 66:904-910.
19. Ellis H: The magnitude of adhesion related problems. Ann Chir Gynaecol 1998; 87:9-11.
20. Diamond MP: Reduction of de novo postsurgical adhesions by intraoperative precoating with sepr acoat (hal-c) solution: A prospective, randomized, blinded, placebo-controlled multicenter study. The sepracoat adhesion study group. Fertil Steril 1998; 69:1067-1074.
21. Shah M, Foreman DM, Ferguson MW: Neutralisation of tgf-beta 1 and tgf-beta 2 or exogenous addition of tgf-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108:985-1002.
22. Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP: Alteration of type i and iii collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound Repair Regen 1999; 7:504-510.
23. Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP: Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia [in process citation]. Am J Reprod Immunol 2000; 43:285-291.
24. Saed GM, Zhang W, Diamond MP: Effect of hypoxia on stimulatory effect of tgf-beta1 on mmp-2 and mmp-9 activities in mouse fibroblasts [in process citation]. J Soc Gynecol Invest 2000; 7: 348-354.
25. Chegini N, Gold LI, Williams RS: Localization of transforming growth factor beta isoforms tgf-beta 1, tgf-beta 2, and tgf-beta 3 in surgically induced endometriosis in the rat. Obstet Gynecol 1994; 83:455-461.
26. Williams RS, Rossi AM, Chegini N, Schultz G: Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res 1992; 52:65-70.
27. Lucas PA, Warejcka DJ, Young HE, Lee BY: Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-beta1. J Surg Res 1996; 65:135-138.
28. Schmid P, Cox D, Bilbe G, McMaster G, Morrison C, Stahelin H, Luscher N, Seiler W: Tgf-betas and tgf-beta type ii receptor in human epidermis: Differential expression in acute and chronic skin wounds. J Pathol 1993; 171:191-197.